<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="276">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05157555</url>
  </required_header>
  <id_info>
    <org_study_id>2021-010-LARYNG-QDV</org_study_id>
    <nct_id>NCT05157555</nct_id>
  </id_info>
  <brief_title>Quality of Life in Patients After Pharyngolaryngectomy</brief_title>
  <acronym>LARYNG-QDV</acronym>
  <official_title>Quality of Life in Patients After Pharyngolaryngectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Université de Reims Champagne-Ardenne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Université de Reims Champagne-Ardenne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Laryngeal cancer is an indication for a laryngectomy (separation of the airways and digestive&#xD;
      tract). Laryngectomy causes a permanent disruption of self-perception. Communication, social&#xD;
      interactions, diet andaesthetic appearance are altered. Its modifications disrupt the quality&#xD;
      of life of patients and must be taken into account as soon as possible in patient cares.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study is to describe quality of life in patients with laryngectomy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2022</start_date>
  <completion_date type="Anticipated">July 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>5 Months</target_duration>
  <primary_outcome>
    <measure>EORTC QLQ-C30</measure>
    <time_frame>Day 0</time_frame>
    <description>The QLQ-C30 is a generic questionnaire with 30 questions coded in 4 response modalities (not at all (1), a little (2), enough (3), a lot (4)) or in 7 response modalities (from very bad (1) to excellent ( 7)).&#xD;
Questions are summarized in five multiitem domains (physical, role, cognitive, emotional, and social functioning) and nine single item domains (fatigue, pain, nausea/vomiting, appetite loss, financial impact; diarrhea, constipation, sleep disturbance and quality of life).&#xD;
Each domain is scored between 0 and 100. For functional domains, a high score value represents a high level of quality of life. For symptom domains, a high score represents an important level of symptoms (a low level of quality of life).</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Laryngectomy; Status</condition>
  <arm_group>
    <arm_group_label>&quot;with laryngectomy&quot; group</arm_group_label>
    <description>&quot;with laryngectomy&quot; group: patients with laryngectomy for any type of cancer</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Data collection</intervention_name>
    <description>Description: quality of life assessment</description>
    <arm_group_label>&quot;with laryngectomy&quot; group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with laryngectomy&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  male or female&#xD;
&#xD;
          -  with laryngectomy&#xD;
&#xD;
          -  agreeing to participate in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - less than 18 years old&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Delphine DORMOIS, IPA</last_name>
    <phone>0326918822</phone>
    <phone_ext>+33</phone_ext>
    <email>delphine.dormois@etudiant.univ-reims.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Coralie BARBE, MD</last_name>
    <phone>0326918822</phone>
    <phone_ext>+33</phone_ext>
    <email>currs@univ-reims.fr</email>
  </overall_contact_backup>
  <verification_date>December 2021</verification_date>
  <study_first_submitted>December 1, 2021</study_first_submitted>
  <study_first_submitted_qc>December 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 15, 2021</study_first_posted>
  <last_update_submitted>December 1, 2021</last_update_submitted>
  <last_update_submitted_qc>December 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Laryngeal cancer - laryngectomy - quality of life</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

